| Value | ₹0.29 Cr |
|---|
BSE filing, NSE: EQUITASBNK. Summary written from the filing by ALFA Finder's alert engine.
Equitas Small Finance Bank Ltd: key numbers
- Share price
- ₹65.13
- Market cap
- ₹7,452 Cr
- Revenue (annual)
- ₹6,794 Cr
- Net profit (annual)
- ₹116.0 Cr
- P/E (TTM)
- 14.6×Sector 19.7×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 15.80%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Equitas Small Finance Bank Ltd
All →Equitas Small Finance Bank Other Announcement
The company submitted its quarterly shareholding pattern for the period ending September 30, 2026. This is a periodic regulatory compliance filing required under SEBI listing regulations.
Equitas Small Finance Bank Board Meeting Date
Equitas Small Finance Bank will hold a board meeting on 29 Oct 2026 to consider unaudited H1 FY27 standalone results. No financial figures are disclosed.
Equitas Small Finance Bank Credit Rating
Equitas Small Finance Bank announced that CARE Ratings reaffirmed the "CARE AA-; Stable" rating for its issuer, Lower Tier II, and Tier II bond issues.
Equitas Small Finance Bank Employee Stock Options
Equitas Small Finance Bank allotted 4,574 equity shares to employees upon the exercise of stock options under its 2019 ESOP scheme.
Equitas Small Finance Bank Other Announcement
Equitas Small Finance Bank notified exchanges about its social media communication regarding the SEBI-mandated special window for the re-lodgement of physical shares.
Equitas Small Finance Bank Business Update
Equitas Small Finance Bank reported provisional business updates for Q2 FY27, with gross advances reaching ₹50,694 Crore. Total deposits grew to ₹52,483 Crore for the period.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date